VYNE Therapeutics (VYNE) Other Gross PP&E Adjustments (2016 - 2025)
VYNE Therapeutics (VYNE) has disclosed Other Gross PP&E Adjustments for 9 consecutive years, with $117000.0 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments rose 387.5% year-over-year to $117000.0, compared with a TTM value of $117000.0 through Dec 2025, up 387.5%, and an annual FY2025 reading of $117000.0, up 387.5% over the prior year.
- Other Gross PP&E Adjustments was $117000.0 for Q4 2025 at VYNE Therapeutics, up from $85000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $905000.0 in Q4 2021 and bottomed at -$1.4 million in Q1 2021.
- Average Other Gross PP&E Adjustments over 4 years is -$261833.3, with a median of -$136500.0 recorded in 2024.
- The sharpest move saw Other Gross PP&E Adjustments increased 18.25% in 2021, then surged 387.5% in 2025.
- Year by year, Other Gross PP&E Adjustments stood at $905000.0 in 2021, then crashed by 122.87% to -$207000.0 in 2023, then surged by 111.59% to $24000.0 in 2024, then soared by 387.5% to $117000.0 in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for VYNE at $117000.0 in Q4 2025, $85000.0 in Q2 2025, and $55000.0 in Q1 2025.